Nurdan Şentürk Durmuş, S. Akın, T. Soysal, G. Zararsiz, Zeynep Türe
{"title":"多重用药频率:COVID-19(+)老年人多重用药与死亡率的关系","authors":"Nurdan Şentürk Durmuş, S. Akın, T. Soysal, G. Zararsiz, Zeynep Türe","doi":"10.4274/ejgg.galenos.2021.478","DOIUrl":null,"url":null,"abstract":"Objective: This study aims to determine the relationship between polypharmacy and Coronavirus disease-2019 (COVID-19) (+) related mortality. Materials and Methods: All older adults >60 years old who had positive COVID-19 polymerase chain reaction tests were included in the study, designed retrospectively. Polypharmacy was defined as drug use of five or more.","PeriodicalId":341534,"journal":{"name":"European Journal of Geriatrics and Gerontology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Polypharmacy Frequency: The Relationship Between Polypharmacy and Mortality in COVID-19 (+) Older Adults\",\"authors\":\"Nurdan Şentürk Durmuş, S. Akın, T. Soysal, G. Zararsiz, Zeynep Türe\",\"doi\":\"10.4274/ejgg.galenos.2021.478\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: This study aims to determine the relationship between polypharmacy and Coronavirus disease-2019 (COVID-19) (+) related mortality. Materials and Methods: All older adults >60 years old who had positive COVID-19 polymerase chain reaction tests were included in the study, designed retrospectively. Polypharmacy was defined as drug use of five or more.\",\"PeriodicalId\":341534,\"journal\":{\"name\":\"European Journal of Geriatrics and Gerontology\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-08-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Geriatrics and Gerontology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4274/ejgg.galenos.2021.478\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Geriatrics and Gerontology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/ejgg.galenos.2021.478","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Polypharmacy Frequency: The Relationship Between Polypharmacy and Mortality in COVID-19 (+) Older Adults
Objective: This study aims to determine the relationship between polypharmacy and Coronavirus disease-2019 (COVID-19) (+) related mortality. Materials and Methods: All older adults >60 years old who had positive COVID-19 polymerase chain reaction tests were included in the study, designed retrospectively. Polypharmacy was defined as drug use of five or more.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
